1. Preoperative intra-arterial infusion chemotherapy for advanced squamous cell carcinoma of the mouth and oropharynx
- Author
-
Suresh Raina, Benjamin F. Rush, John Milazzo, Anangur P. Swaminathan, Mirseyed A. Mohit-Tabatabai, Kumar S. Dasmahapatra, George J. Hill, and Nae K. Cheung
- Subjects
Cisplatin ,Cancer Research ,medicine.medical_specialty ,Chemotherapy ,business.industry ,medicine.medical_treatment ,Bleomycin ,Surgery ,Vinblastine ,Radiation therapy ,chemistry.chemical_compound ,Oncology ,Infusion therapy ,chemistry ,Fluorouracil ,medicine ,Adjuvant therapy ,business ,medicine.drug - Abstract
Twelve patients with advanced locoregional (Stage III and IV) squamous cell carcinoma of the oral cavity and oropharynx underwent treatment with cisplatin, vinblastine, bleomycin, and 5-fluorouracil, given by intra-arterial infusion, as primary adjuvant therapy, in preparation for radiation therapy and surgery. Responses were observed during or immediately after infusion therapy in 8 of 12 (67%) of patients (1 complete response, 7 partial responses). Infusion chemotherapy was followed by radiation therapy alone in five patients and by radiation and surgery in six patients. The protocol was initiated in August 1981, and six patients are now free of their primary cancer, at 21 to 36 months, whereas six have died with disease. Arterial infusion of a combination of effective antineoplastic agents is a promising method for the preparation of selected patients for radiation therapy and surgery, as it is less likely to produce serious systemic toxicity and it requires a shorter period than systemic neoadjuvant chemotherapy.
- Published
- 1985